Davies, D M; de Vries, P J; Johnson, S R; McCartney, D L; Cox, J A; Serra, A L; Watson, P C; Howe, C J; Doyle, T; Pointon, K; Cross, J J; Tattersfield, A E; Kingswood, J C; Sampson, J R (2011). Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clinical Cancer Research, 17(12):4071-4081.
This study showed sustained regression of renal angiomyolipomas in patients with tuberous sclerosis or sporadic LAM receiving 2 years of sirolimus treatment. Possible effects on pulmonary function and neurocognition require further investigation.
This study showed sustained regression of renal angiomyolipomas in patients with tuberous sclerosis or sporadic LAM receiving 2 years of sirolimus treatment. Possible effects on pulmonary function and neurocognition require further investigation.
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Nephrology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Oncology
Life Sciences > Cancer Research |
| Language: | English |
| Date: | 2011 |
| Deposited On: | 07 Dec 2011 12:23 |
| Last Modified: | 30 Jul 2020 02:13 |
| Publisher: | American Association for Cancer Research |
| ISSN: | 1078-0432 |
| OA Status: | Hybrid |
| Publisher DOI: | https://doi.org/10.1158/1078-0432.CCR-11-0445 |
| PubMed ID: | 21525172 |
Davies, D M